RCT QOL study - HDR vs LDR prostate boost
Faster GU recovery w HDR, LDR w GI issues for longer
Both w reasonable toxicities and much less than seen in ASCENDE...technique matters!
https://t.co/IG58HiZAYG
Dr Nikitha Moideen #presents an RCT of LDR versus HDR boost in #radiotherapy for #prostatecancer. N=195, median FU 48mo. Study powered for toxicity. Unexpected late bowel for LDR #ASTRO22
Congrats @nikimoideen and Dr Crook on the fantastic trial comparing QOL after HDR vs LDR boost at #ABS22. This is a critical study for #brachytherapy. Very happy to have you joining @OttawaHospital in a few short months!
Incredible session on image guided gyn Brachy @AmerBrachy#ABSbrachy2022. Reassuring to see that needle intrusions are associated with low rates of high risk complications. Great summary by @NeilTaunkMD based on @lucascmendez data.